Product Details for: Uplizna

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
100MG/10ML (10MG/ML)
Single-Dose Vial
351(a)
Uplizna
Rx
Proper Name
inebilizumab-cdon
BLA Number
761142
Applicant
Horizon Therapeutics Ireland DAC
Original Approval Date
June 11, 2020
Date of First Licensure
RETURN TO SEARCH RESULTS